We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

221 hedge funds and large institutions have $1.74B invested in Adaptive Biotechnologies in 2022 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 88 increasing their positions, 48 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 48

26% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 39

3% more funds holding

Funds holding: 214 → 221 (+7)

1.23% more ownership

Funds ownership: 87.48% → 88.71% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

43% less call options, than puts

Call options by funds: $1.19M | Put options by funds: $2.09M

50% less capital invested

Capital invested by funds: $3.46B → $1.74B (-$1.72B)

Holders
221
Holders Change
+7
Holders Change %
+3.27%
% of All Funds
3.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
49
Increased
88
Reduced
48
Closed
39
Calls
$1.19M
Puts
$2.09M
Net Calls
-$904K
Net Calls Change
-$6.13M

Top Buyers

1
AIM
ARK Investment Management
Florida
+$31.6M
2
BG
Bellevue Group
Switzerland
+$18.5M
3
NAMA
Nikko Asset Management Americas
New York
+$15.4M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$14.7M
5
Marshall Wace
Marshall Wace
United Kingdom
+$13.3M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$58.8M
2
GGHC
Gilder Gagnon Howe & Co
New York
-$26.5M
3
Invesco
Invesco
Georgia
-$22.1M
4
ZCI
Zevenbergen Capital Investments
Washington
-$19.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$416M – – –
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$172M -$13.7M -870,346 -7%
MCMC
3
Matrix Capital Management Company
New Hampshire
$161M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$154M +$936K +59,546 +0.5%
AIM
5
ARK Investment Management
Florida
$107M +$31.6M +2,011,798 +35%
BlackRock
6
BlackRock
New York
$82.8M +$7.81M +496,512 +9%
Sumitomo Mitsui Trust Group
7
Sumitomo Mitsui Trust Group
Japan
$57.4M +$14.7M +936,614 +29%
NAMA
8
Nikko Asset Management Americas
New York
$56.5M +$15.4M +979,855 +31%
BG
9
Bellevue Group
Switzerland
$43.7M +$18.5M +1,176,862 +60%
Massachusetts Financial Services
10
Massachusetts Financial Services
Massachusetts
$39.9M +$7.07M +449,383 +19%
State Street
11
State Street
Massachusetts
$26M +$3.83M +243,581 +15%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$19.6M -$377K -23,947 -2%
Neuberger Berman Group
13
Neuberger Berman Group
New York
$17.6M -$11.5M -734,571 -37%
Goldman Sachs
14
Goldman Sachs
New York
$16.3M -$2.25M -143,271 -11%
Norges Bank
15
Norges Bank
Norway
$14.8M +$422K +26,846 +3%
EHI
16
Eagle Health Investments
Connecticut
$14.1M +$4.15M +264,100 +35%
CC
17
Casdin Capital
New York
$13.9M – – –
SIG
18
Senator Investment Group
New York
$13.9M – – –
Marshall Wace
19
Marshall Wace
United Kingdom
$12.8M +$13.3M +845,225 +1,053%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$12.6M -$368K -23,418 -3%
Charles Schwab
21
Charles Schwab
California
$11.9M +$300K +19,097 +2%
TCM
22
TimesSquare Capital Management
New York
$10.9M -$3.55M -225,600 -22%
AAP
23
Aristotle Atlantic Partners
Florida
$10.5M +$214K +13,617 +2%
Ameriprise
24
Ameriprise
Minnesota
$9M +$1.07M +68,205 +12%
FCM
25
Frontier Capital Management
Massachusetts
$8.29M +$6.36M +404,561 +210%
1
2 3 4 5

ADPT Hedge Fund Activity: Q1 2022 in Review

221 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q1 2022, worth a combined $1.74B — down 50% from $3.46B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new ADPT positions and 39 closed out — a net gain of 10 holders — while 88 added to existing stakes and 48 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $31.6M. The largest seller was Capital International Investors, exiting entirely with an estimated $58.8M sold.

  • 221 institutional investors held Adaptive Biotechnologies (ADPT) as of Q1 2022, up from 214 in Q4 2021.
  • Funds reported $1.74B of Adaptive Biotechnologies stock for Q1 2022, down 50% quarter-over-quarter.
  • 49 funds opened new Adaptive Biotechnologies positions in Q1 2022 and 39 closed out, a net change of +10 holders.
  • The largest Adaptive Biotechnologies buyer in Q1 2022 was ARK Investment Management, an estimated $31.6M added.
  • The largest Adaptive Biotechnologies seller in Q1 2022 was Capital International Investors, an estimated $58.8M sold.

Based on aggregated 13F filings for Q1 2022.